This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Gopikishan Tonukunuru: Innovator in Pharmaceutical Compounds
Introduction
Gopikishan Tonukunuru is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate T cells. With a total of five patents to his name, his work is paving the way for advancements in medical treatments.
Latest Patents
Among his latest patents, Gopikishan has developed substituted naphthyridinone compounds that are useful as T cell activators. These compounds are designed to inhibit the activity of diacylglycerol kinase alpha (DGKα) and diacylglycerol kinase zeta (DGKζ). The pharmaceutical compositions comprising these compounds are particularly useful in treating viral infections and proliferative disorders, such as cancer.
Career Highlights
Gopikishan currently works at Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His research focuses on creating effective treatments that can significantly impact patient care and outcomes.
Collaborations
He collaborates with talented coworkers, including Jayakumar Sankara Warrier and Hasibur Rahaman, who contribute to his research and development efforts.
Conclusion
Gopikishan Tonukunuru is a prominent figure in the field of pharmaceutical innovations, with a focus on T cell activation compounds. His work is essential in the ongoing fight against viral infections and cancer, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile